Will biotech investors cheer the impending round of IPOs?

A half-dozen biotech IPOs will roll out over the next 8 days, on top of 22 first-time public offerings in the industry so far this year. This batch has a combined money-raising goal of $350 million. Will investors cooperate with those hopes? Report